Skip to content
OpenCapital
Get started

Solventum SOLV Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies

3M logo
3MMMM
-$2.12B-403%
Baxter International logo
Baxter InternationalBAX
-$11M+99.7%
Medline, Inc. logo
Medline, Inc. MDLN
-$13M-44.4%
Globus Medical logo
Globus MedicalGMED
——
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
——
Nordson logo
NordsonNDSN
——

Other financials

Income statement

See full
Revenue$2.0B-3.0%
Gross profit$1.1B-1.5%
Operating income$81.0M-46.7%
Net income$13.0M-90.5%
EPS (diluted)$0.07-91.0%

Balance sheet

See full
Cash & equivalents$561.0M+5.1%
Total debt$5.8B-26.8%
Total equity$5.0B+52.3%
Total assets$14.1B-3.0%

Cash flow

See full
Operating cash flow-$189.0M-752%
CapEx$84.0M-22.9%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$13.06B-13.9%
Enterprise value$18.29B-19.4%
P/E9.1×-30.9×
P/S1.6×-0.2×

Profitability

See full
Gross margin53.7%-0.9pp
Operating margin25.5%+15.8pp
Net margin17.3%+12.8pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34.8%+24.1pp
Debt / equity1.2×-1.3×
Current ratio1.1×-0.1×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solventum's cash provided by (used in) financing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solventum's cash provided by (used in) financing activity, including discontinued operation?
Solventum (SOLV) reported cash provided by (used in) financing activity, including discontinued operation of -$50M in Q1 2026.
How has Solventum's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
Solventum's cash provided by (used in) financing activity, including discontinued operation increased by 64.0% year-over-year, from -$139M to -$50M.
What is the long-term trend for Solventum's cash provided by (used in) financing activity, including discontinued operation?
Over 3 years (2022 to 2025), Solventum's cash provided by (used in) financing activity, including discontinued operation has grown at a 27.9% compound annual growth rate (CAGR), from -$1.46B to -$3.06B.